LIMES SCHLOSSKLINIKEN AG (LIK.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:LIK - DE000A0JDBC7 - Common Stock
360 EUR
+6 (+1.69%)
Taking everything into account, LIK scores 6 out of 10 in our fundamental rating. LIK was compared to 29 industry peers in the Health Care Providers & Services industry. LIK gets an excellent profitability rating and is at the same time showing great financial health properties. LIK is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make LIK a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
LIK had positive earnings in the past year.
Of the past 5 years LIK 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: LIK reported negative operating cash flow in multiple years.
1.2 Ratios
LIK has a Return On Assets of 10.51%. This is amongst the best in the industry. LIK outperforms 100.00% of its industry peers.
With an excellent Return On Equity value of 20.85%, LIK belongs to the best of the industry, outperforming 96.55% of the companies in the same industry.
LIK has a better Return On Invested Capital (15.26%) than 100.00% of its industry peers.
LIK had an Average Return On Invested Capital over the past 3 years of 15.32%. This is significantly above the industry average of 6.33%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.51% | ||
| ROE | 20.85% | ||
| ROIC | 15.26% |
ROA(3y)11.35%
ROA(5y)9.91%
ROE(3y)25.76%
ROE(5y)22.78%
ROIC(3y)15.32%
ROIC(5y)N/A
1.3 Margins
LIK's Profit Margin of 10.81% is amongst the best of the industry. LIK outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of LIK has declined.
LIK has a better Operating Margin (16.42%) than 100.00% of its industry peers.
LIK's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 95.03%, LIK belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
LIK's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.42% | ||
| PM (TTM) | 10.81% | ||
| GM | 95.03% |
OM growth 3Y-14.42%
OM growth 5YN/A
PM growth 3Y-19.47%
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y-0.06%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LIK is creating value.
The number of shares outstanding for LIK remains at a similar level compared to 1 year ago.
LIK has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for LIK has been reduced compared to a year ago.
2.2 Solvency
LIK has an Altman-Z score of 5.24. This indicates that LIK is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.24, LIK belongs to the top of the industry, outperforming 96.55% of the companies in the same industry.
LIK has a Debt/Equity ratio of 0.56. This is a neutral value indicating LIK is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.56, LIK belongs to the top of the industry, outperforming 86.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.24 |
ROIC/WACC2.21
WACC6.92%
2.3 Liquidity
A Current Ratio of 3.25 indicates that LIK has no problem at all paying its short term obligations.
LIK has a Current ratio of 3.25. This is amongst the best in the industry. LIK outperforms 100.00% of its industry peers.
A Quick Ratio of 3.23 indicates that LIK has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.23, LIK belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.25 | ||
| Quick Ratio | 3.23 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.76% over the past year.
LIK shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.60% yearly.
LIK shows a decrease in Revenue. In the last year, the revenue decreased by -0.13%.
Measured over the past years, LIK shows a very strong growth in Revenue. The Revenue has been growing by 35.58% on average per year.
EPS 1Y (TTM)6.76%
EPS 3Y-7.6%
EPS 5YN/A
EPS Q2Q%81.09%
Revenue 1Y (TTM)-0.13%
Revenue growth 3Y14.74%
Revenue growth 5Y35.58%
Sales Q2Q%23.74%
3.2 Future
The Earnings Per Share is expected to grow by 36.66% on average over the next years. This is a very strong growth
LIK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.37% yearly.
EPS Next Y9.79%
EPS Next 2Y33.32%
EPS Next 3Y36.66%
EPS Next 5YN/A
Revenue Next Year13.89%
Revenue Next 2Y21.91%
Revenue Next 3Y21.37%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 22.97, the valuation of LIK can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of LIK indicates a slightly more expensive valuation: LIK is more expensive than 62.07% of the companies listed in the same industry.
LIK's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.60.
Based on the Price/Forward Earnings ratio of 11.43, the valuation of LIK can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LIK indicates a somewhat cheap valuation: LIK is cheaper than 75.86% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.23, LIK is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.97 | ||
| Fwd PE | 11.43 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LIK indicates a slightly more expensive valuation: LIK is more expensive than 65.52% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.84 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LIK does not grow enough to justify the current Price/Earnings ratio.
LIK has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as LIK's earnings are expected to grow with 36.66% in the coming years.
PEG (NY)2.35
PEG (5Y)N/A
EPS Next 2Y33.32%
EPS Next 3Y36.66%
5. Dividend
5.1 Amount
LIK does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:LIK (1/2/2026, 7:00:00 PM)
360
+6 (+1.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners7.29%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap104.40M
Revenue(TTM)42.54M
Net Income(TTM)4.60M
Analysts80
Price Target612 (70%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-29.25%
EPS NY rev (3m)-29.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-11.93%
Revenue NY rev (3m)-11.93%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.97 | ||
| Fwd PE | 11.43 | ||
| P/S | 2.45 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 4.73 | ||
| P/tB | 7.43 | ||
| EV/EBITDA | 10.84 |
EPS(TTM)15.67
EY4.35%
EPS(NY)31.49
Fwd EY8.75%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS146.68
BVpS76.04
TBVpS48.46
PEG (NY)2.35
PEG (5Y)N/A
Graham Number163.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.51% | ||
| ROE | 20.85% | ||
| ROCE | 18.69% | ||
| ROIC | 15.26% | ||
| ROICexc | 21.72% | ||
| ROICexgc | 31.24% | ||
| OM | 16.42% | ||
| PM (TTM) | 10.81% | ||
| GM | 95.03% | ||
| FCFM | N/A |
ROA(3y)11.35%
ROA(5y)9.91%
ROE(3y)25.76%
ROE(5y)22.78%
ROIC(3y)15.32%
ROIC(5y)N/A
ROICexc(3y)23.25%
ROICexc(5y)N/A
ROICexgc(3y)57.5%
ROICexgc(5y)N/A
ROCE(3y)18.77%
ROCE(5y)N/A
ROICexgc growth 3Y-31.59%
ROICexgc growth 5YN/A
ROICexc growth 3Y-14.79%
ROICexc growth 5YN/A
OM growth 3Y-14.42%
OM growth 5YN/A
PM growth 3Y-19.47%
PM growth 5YN/A
GM growth 3Y-0.09%
GM growth 5Y-0.06%
F-ScoreN/A
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.26 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.25 | ||
| Quick Ratio | 3.23 | ||
| Altman-Z | 5.24 |
F-ScoreN/A
WACC6.92%
ROIC/WACC2.21
Cap/Depr(3y)160.08%
Cap/Depr(5y)N/A
Cap/Sales(3y)11.64%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.76%
EPS 3Y-7.6%
EPS 5YN/A
EPS Q2Q%81.09%
EPS Next Y9.79%
EPS Next 2Y33.32%
EPS Next 3Y36.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.13%
Revenue growth 3Y14.74%
Revenue growth 5Y35.58%
Sales Q2Q%23.74%
Revenue Next Year13.89%
Revenue Next 2Y21.91%
Revenue Next 3Y21.37%
Revenue Next 5YN/A
EBIT growth 1Y28.44%
EBIT growth 3Y-1.81%
EBIT growth 5YN/A
EBIT Next Year61.61%
EBIT Next 3Y44.28%
EBIT Next 5Y29.34%
FCF growth 1Y890.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.63%
OCF growth 3YN/A
OCF growth 5YN/A
LIMES SCHLOSSKLINIKEN AG / LIK.DE FAQ
What is the ChartMill fundamental rating of LIMES SCHLOSSKLINIKEN AG (LIK.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to LIK.DE.
What is the valuation status for LIK stock?
ChartMill assigns a valuation rating of 4 / 10 to LIMES SCHLOSSKLINIKEN AG (LIK.DE). This can be considered as Fairly Valued.
How profitable is LIMES SCHLOSSKLINIKEN AG (LIK.DE) stock?
LIMES SCHLOSSKLINIKEN AG (LIK.DE) has a profitability rating of 7 / 10.
What is the valuation of LIMES SCHLOSSKLINIKEN AG based on its PE and PB ratios?
The Price/Earnings (PE) ratio for LIMES SCHLOSSKLINIKEN AG (LIK.DE) is 22.97 and the Price/Book (PB) ratio is 4.73.